Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Solarase approved in Canada

May 25, 1998

TGF-beta3 proves ineffective for the treatment of oral mucositis

May 22, 1998

SmithKline Beecham and Leo will collaborate on dermatological R&D

May 21, 1998

IL-8 receptor antagonists described by SKB

May 19, 1998

FDA grants approval for pivotal clinical trial of Repel

May 12, 1998

Compounds for IL-8-mediated diseases in development at SmithKline Beecham

May 11, 1998

Ortec's CCS granted humanitarian use device designation

May 11, 1998

Favorable results obtained in SomatoKine burn study

May 7, 1998

Solarase receives additional European approvals

May 5, 1998

Topical BCX-34 not effective in phase II

May 4, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
How to Summit up? Dis-Harmoni on ivonescimab NSCLC phase III
BioWorld
Wall Street pundits were divided about the likely fate of ivonescimab, Summit Therapeutics Inc.’s bispecific antibody partnered with Akeso Pharmaceuticals Inc.,...